69 related articles for article (PubMed ID: 2134051)
1. Structure-activity studies with cholecystokinin: stereoisomers containing ortho-, meta- and para-tyrosine sulfate.
Stanfield CF; Felix AM; Danho W
Pept Res; 1990; 3(2):69-72. PubMed ID: 2134051
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological activity of novel, potent and long-acting analogs of AC-CCK-7 with high affinity for peripheral (type A) receptors.
Danho W; Makofske RC; Swistok J; Michalewsky J; Gabriel T; Marks N; Berg MJ; Baird L; Geiler V; Mackie G
Pept Res; 1991; 4(2):59-65. PubMed ID: 1815779
[TBL] [Abstract][Full Text] [Related]
3. Stabilization of a tyrosine O-sulfate residue by a cationic functional group: formation of a conjugate acid-base pair.
Yagami T; Kitagawa K; Aida C; Fujiwara H; Futaki S
J Pept Res; 2000 Oct; 56(4):239-49. PubMed ID: 11083063
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships for myotropic activity of the gastrin/cholecystokinin-like insect sulfakinins.
Nachman RJ; Holman GM; Haddon WF; Hayes TK
Pept Res; 1989; 2(2):171-7. PubMed ID: 2520754
[TBL] [Abstract][Full Text] [Related]
5. Plant peptide hormone phytosulfokine (PSK-alpha): synthesis of new analogues and their biological evaluation.
Bahyrycz A; Matsubayashi Y; Ogawa M; Sakagami Y; Konopińska D
J Pept Sci; 2004 Jul; 10(7):462-9. PubMed ID: 15298181
[TBL] [Abstract][Full Text] [Related]
6. PEGylation of cholecystokinin prolongs its anorectic effect in rats.
León-Tamariz F; Verbaeys I; Van Boven M; De Cuyper M; Buyse J; Clynen E; Cokelaere M
Peptides; 2007 May; 28(5):1003-11. PubMed ID: 17379357
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the final deprotection system for the solid-phase synthesis of Tyr(SO3H)-containing peptides with 9-fluorenylmethyloxycarbonyl (Fmoc)-strategy and its application to the synthesis of cholecystokinin (CCK)-12.
Yagami T; Shiwa S; Futaki S; Kitagawa K
Chem Pharm Bull (Tokyo); 1993 Feb; 41(2):376-80. PubMed ID: 8500203
[TBL] [Abstract][Full Text] [Related]
8. The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors.
Boteju LW; Nikiforovich GV; Haskell-Luevano C; Fang SN; Zalewska T; Stropova D; Yamamura HI; Hruby VJ
J Med Chem; 1996 Sep; 39(20):4120-4. PubMed ID: 8831778
[TBL] [Abstract][Full Text] [Related]
9. Aliphatic amino diacid Asu functions as an effective mimic of Tyr(SO3H) in sulfakinins for myotropic and food intake-inhibition activity in insects.
Nachman RJ; Vercammen T; Williams H; Kaczmarek K; Zabrocki J; Schoofs L
Peptides; 2005 Jan; 26(1):115-20. PubMed ID: 15626511
[TBL] [Abstract][Full Text] [Related]
10. Further evidence for a C-terminal structural motif in CCK2 receptor active peptide hormones.
Stone SR; Giragossian C; Mierke DF; Jackson GE
Peptides; 2007 Nov; 28(11):2211-22. PubMed ID: 17950490
[TBL] [Abstract][Full Text] [Related]
11. Facile solid-phase synthesis of sulfated tyrosine-containing peptides: total synthesis of human big gastrin-II and cholecystokinin (CCK)-39.
Kitagawa K; Aida C; Fujiwara H; Yagami T; Futaki S; Kogire M; Ida J; Inoue K
J Org Chem; 2001 Jan; 66(1):1-10. PubMed ID: 11429884
[TBL] [Abstract][Full Text] [Related]
12. Trace quantification of the oxidative damage products, meta- and ortho-tyrosine, in biological samples by gas chromatography-electron capture negative ionization mass spectrometry.
Blount BC; Duncan MW
Anal Biochem; 1997 Jan; 244(2):270-6. PubMed ID: 9025943
[TBL] [Abstract][Full Text] [Related]
13. Liquid secondary-ion mass spectrometry of peptides containing multiple tyrosine-O-sulfates.
Yagami T; Kitagawa K; Futaki S
Rapid Commun Mass Spectrom; 1995; 9(14):1335-41. PubMed ID: 8534883
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of potent heptapeptide analogues of cholecystokinin.
Penke B; Hajnal F; Lonovics J; Holzinger G; Kadar T; Telegdy G; Rivier J
J Med Chem; 1984 Jul; 27(7):845-9. PubMed ID: 6737428
[TBL] [Abstract][Full Text] [Related]
15. Sequence variation outside the "active" region of dog and rabbit cholecystokinin-58 results in bioactivity differences.
Reeve JR; Liddle RA; Shively JE; Lee TD; Keire DA; Chew P; Vigna SR
Pancreas; 2006 Apr; 32(3):306-13. PubMed ID: 16628087
[TBL] [Abstract][Full Text] [Related]
16. Conformationally readdressed CCK-B/delta-opioid peptide ligands.
Nikiforovich GV; Kolodziej SA; Nock B; Bernad N; Martinez J; Marshall GR
Biopolymers; 1995 Oct; 36(4):439-52. PubMed ID: 7578939
[TBL] [Abstract][Full Text] [Related]
17. Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.
Gigoux V; Maigret B; Escrieut C; Silvente-Poirot S; Bouisson M; Fehrentz JA; Moroder L; Gully D; Martinez J; Vaysse N; Fourmy AD
Protein Sci; 1999 Nov; 8(11):2347-54. PubMed ID: 10595537
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the behavioral activity of C- and N-terminal fragments of cholecystokinin octapeptide.
Crawley JN; St-Pierre S; Gaudreau P
J Pharmacol Exp Ther; 1984 Aug; 230(2):438-44. PubMed ID: 6086888
[TBL] [Abstract][Full Text] [Related]
19. Analogs of Ac-CCK-7 incorporating dipeptide mimics in place of Met28-Gly29.
Tilley JW; Danho W; Shiuey SJ; Kulesha I; Swistok J; Makofske R; Michalewsky J; Triscari J; Nelson D; Weatherford S
J Med Chem; 1992 Oct; 35(21):3774-83. PubMed ID: 1433191
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of potent, selective, hexapeptide CCK-A agonist anorectic agents.
Pierson ME; Comstock JM; Simmons RD; Kaiser F; Julien R; Zongrone J; Rosamond JD
J Med Chem; 1997 Dec; 40(26):4302-7. PubMed ID: 9435899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
